MeSH D006527 - hepatolenticular degeneration
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Penicillamine | Penicillamine | 2020-02-13 | |||
| Mylan | Penicillamine | Depen | 1982-01-01 | |||
| Cipla | Penicillamine | Penicillamine | 2021-08-19 | |||
| Lupin Research | Penicillamine | Penicillamine | 2020-11-30 | |||
| Trientine | Trientine | 2020-05-21 | ||||
| Bausch Health Companies | Penicillamine | Cuprimine | 1982-01-01 | |||
| Trientine | Syprine | 1985-11-08 | ||||
| Dr Reddys Laboratories | Penicillamine | Penicillamine | 2020-08-04 | |||
| Trientine | Trientine | 2019-07-03 | ||||
| Apotex | Penicillamine | Penicillamine | 2020-04-28 | |||
| Breckenridge Pharmaceutical | Penicillamine | Penicillamine | 2021-08-23 | |||
| Endo | Penicillamine | Penicillamine | 2019-12-23 | |||
| Trientine | Trientine | 2019-09-25 | ||||
| ANI Pharmaceuticals | Penicillamine | Penicillamine | 2019-05-07 |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
33%1/3
Phase 2
0%0/0
Phase 3
100%2/2
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use